Phenobarbital is a prototype chemical widely known for its propensity to induce expression of a number of biotransformation systems, including microsomal epoxide hydrolase, UDP-glucuronyltransferase, certain glutathione transferases, and some members of the cyotchrome P450 monooxygenase gene superfamily. Together these enyzmes attack a broad array of endogenous and xenobiotic substances. The balance between activation versus detoxication pathways, potentially perturbed by inducers such as PB, will dictate individual susceptibility to mutagenic, carcinogenic, teratogenic, and otherwise toxic effects associated with exposures to certain environmental chemicals. This research program seeks to examine expression mechanisms for PB-inducible members of the CYP2B subfamily of P450s, for which little molecular data is available. The CYP2Bl and CYP2B2 genes are the primary systems under analysis. Their transcription is largely repressed in most tissues, but markedly activated in rat liver upon PB exposure. Through the use of molecular approaches, our primary aims are to: 1) identify critical sequence elements within these genes that confer PB responsiveness; 2) identify repressor/silencer sequence elements responsible for the low levels of constitutive expression observed normally in most tissues; and, 3) characterize novel regulatory proteins, identified as key positive or negative transcriptional modulators. Isolated P450 genes will be analyzed with a battery of techniques, including DNase I hypersensitivity determinations, DNA footprinting and gel retardation assays, in vitro expression of P450/chloramphenicol acetyl transferase gene fusion constructs, direct expression of P450 genes in cultured cells, and in vitro reverse transcription procedures. The results of these experiments should enable a detailed level of understanding of the molecular events responsible for PB-inducible gene regulation. These investigations will provide a framework for determining the genetic basis underlying differential susceptibilities of individuals to the toxic effects associated with chemical exposures.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM032281-07
Application #
3280964
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1984-04-01
Project End
1994-08-31
Budget Start
1991-09-30
Budget End
1992-08-31
Support Year
7
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Public Health
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Yamamoto, Midori; Mise, Masashi; Matsumoto, Sanae et al. (2004) Comparison of genomic and cDNA sequences of guinea pig CYP2B18 and rat CYP2B2: absence of a phenobarbital-responsive enhancer module in the upstream region of the CYP2B18 gene. J Biochem Mol Toxicol 18:124-30
Sidhu, Jaspreet S; Liu, Fei; Omiecinski, Curtis J (2004) Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. Exp Cell Res 292:252-64
Beck, N B; Sidhu, J S; Omiecinski, C J (2000) Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes. Gene Ther 7:1274-83
Omiecinski, C J; Remmel, R P; Hosagrahara, V P (1999) Concise review of the cytochrome P450s and their roles in toxicology. Toxicol Sci 48:151-6
Sidhu, J S; Omiecinski, C J (1999) Insulin-mediated modulation of cytochrome P450 gene induction profiles in primary rat hepatocyte cultures. J Biochem Mol Toxicol 13:1-9
Ramsden, R; Beck, N B; Sommer, K M et al. (1999) Phenobarbital responsiveness conferred by the 5'-flanking region of the rat CYP2B2 gene in transgenic mice. Gene 228:169-79
Beck, N B; Omiecinski, C J (1999) Lack of modulation by phenobarbital of cyclic AMP levels or protein kinase A activity in rat primary hepatocytes. Biochem Pharmacol 58:1109-14
Hassett, C; Laurenzana, E M; Sidhu, J S et al. (1998) Effects of chemical inducers on human microsomal epoxide hydrolase in primary hepatocyte cultures. Biochem Pharmacol 55:1059-69
Sidhu, J S; Omiecinski, C J (1998) Protein synthesis inhibitors exhibit a nonspecific effect on phenobarbital-inducible cytochome P450 gene expression in primary rat hepatocytes. J Biol Chem 273:4769-75
Sidhu, J S; Omiecinski, C J (1997) An okadaic acid-sensitive pathway involved in the phenobarbital-mediated induction of CYP2B gene expression in primary rat hepatocyte cultures. J Pharmacol Exp Ther 282:1122-9

Showing the most recent 10 out of 33 publications